Results 81 to 90 of about 416,886 (234)

The direct and indirect effects of the pneumococcal conjugated vaccine on carriage rates in children aged younger than 5 years in Latin America and the Caribbean: a systematic review

open access: yesEinstein (São Paulo)
Objective To demonstrate the impact of pneumococcal conjugate vaccine in Streptococcus pneumoniae carriage status in children younger than 5 years in Latin America and the Caribbean. Methods A systematic literature review was carried out on the direct
Stefany Martins Silva   +3 more
doaj   +2 more sources

Nontumor‐Specific mRNA Sensitization of Cold Tumors to Immune Checkpoint Blockade: Evidence, Bias, and Requirements for Translation

open access: yesAdvanced Oncology, Volume 1, Issue 1, December 2026.
Messenger RNA constructs encoding nontumor antigens are proposed to sensitize cold tumors to checkpoint blockade. Observational survival estimates favor vaccination but are heterogeneous, and bias‐focused analyses find no significant difference once time‐zero is aligned. Epitope spreading remains undemonstrated in humans. This review separates what the
Sarfaraz K. Niazi
wiley   +1 more source

Determinants of Age‐Appropriate Childhood Immunization Uptake: A Cross‐Sectional Study of Caregiver, Child, Knowledge, Access, and Attitudinal Factors

open access: yesPublic Health Challenges, Volume 5, Issue 4, December 2026.
Full immunization for age was achieved by 71.7% of children. Caregiver education, health facility delivery, rural residence, regular community immunization services, and positive caregiver attitudes significantly increased coverage, highlighting the need to strengthen primary health care services, health education, and equitable access to routine ...
Aruwa Simon Ayigu   +3 more
wiley   +1 more source

Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia

open access: yes, 2023
BACKGROUND: Patients with chronic lymphocytic leukemia (CLL) show an immune dysfunction with increased risk of infections and poor response to vaccination. Streptococcus pneumoniae is a common cause of morbidity and mortality in CLL patients.
Eva Kimby   +17 more
core   +1 more source

An overview of the clinical development of the 20-valent pneumococcal conjugate vaccine in adults

open access: yesHuman Vaccines & Immunotherapeutics
The 20-valent pneumococcal conjugate vaccine (PCV20) was developed to expand protection against vaccine-preventable disease caused by Streptococcus pneumoniae beyond the 13-valent pneumococcal conjugate vaccine (PCV13).
Kathleen McElwee   +7 more
doaj   +1 more source

Pneumococcal pneumonia and carriage in Africa before and after introduction of pneumococcal conjugate vaccines, 2000–2019: protocol for systematic review

open access: yesBMJ Open, 2019
Introduction Africa harbours a high burden of pneumococcal disease, with associated high mortality rates. Despite 34 countries introducing the pneumococcal conjugate vaccine, which reduces the risk of pneumococcal carriage (a prerequisite for disease) of
Neil French   +7 more
doaj   +1 more source

Cancer co‐medication quality in older patients with polypharmacy: A large randomized trial testing a medication review versus usual care

open access: yesJournal of Internal Medicine, Volume 300, Issue 6, Page 802-820, December 2026.
Abstract Background Evidence from randomized controlled trials (RCTs) testing medication reviews in geriatric oncology is sparse. Methods We conducted a single‐blinded RCT in ten rehabilitation clinics across Germany. Patients with common cancers, aged ≥ 65 years, and polypharmacy (regularly ≥ five drugs) were randomly allocated in equal proportions to
Miriam Degen   +15 more
wiley   +1 more source

Vaccine Coverage and Vaccination Delays in Children With Chronic Illness: A French Multicentre Point‐Prevalence Survey

open access: yes
Acta Paediatrica, EarlyView.
F. Dubos   +18 more
wiley   +1 more source

Bispecific antibodies targeting B‐cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions

open access: yesCancer, Volume 132, Issue 22, 15 November 2026.
Abstract Anti‐B cell maturation antigen (BCMA) therapies, including antibody‐drug conjugates, chimeric antigen receptor T cells, and bispecific antibodies (bsAbs), have recently revolutionized the treatment landscape of multiple myeloma. This review outlines the biologic rationale for targeting BCMA and sheds light on the mechanism of action of bsAbs ...
Enrica Manzato   +5 more
wiley   +1 more source

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

open access: yes, 2010
In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance.
Perrocheau, Anne   +44 more
core   +1 more source

Home - About - Disclaimer - Privacy